Status:
NOT_YET_RECRUITING
Feasibility Study to Actively Disseminate the Latin America and the Caribbean Code Against Cancer in Primary Healthcare Centers
Lead Sponsor:
Hospital Israelita Albert Einstein
Collaborating Sponsors:
International Agency for Research on Cancer
Conditions:
Cancer
Latin America and the Caribbean Code Against Cancer (LAC Code)
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Phase II non-randomized four-arm study (before/after pragmatic trial) that will test 2 different implementation strategies either combined or separately for the dissemination of the Latin America and ...
Eligibility Criteria
Inclusion
- Adults (≥18 years old)
- Registered at a participating primary healthcare center (UBS) in Aparecida de Goiânia
- Healthcare professionals with at least three months of employment at a participating UBS
- Ability to provide informed consent
Exclusion
- \- Prior diagnosis of any cancer or currently undergoing cancer treatment
Key Trial Info
Start Date :
May 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 1 2025
Estimated Enrollment :
1200 Patients enrolled
Trial Details
Trial ID
NCT06965608
Start Date
May 1 2025
End Date
November 1 2025
Last Update
May 11 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
HMAP - Hospital Municipal de Aparecida de Goiânia
Aparecida de Goiânia, Goiás, Brazil